Clopidogrel Bouchara-Recordati
Clopidogrel Bouchara-Recordati Uses, Dosage, Side Effects, Food Interaction and all others data.
(Clopidogrel Bouchara-Recordati) is an inhibitor of platelet aggregation. Lopirel (Clopidogrel Bouchara-Recordati) selectively inhibits the binding of adenosine diphosphate (ADP) to its platelet receptor and the subsequent ADP-mediated activation of the glycoprotein GPIIb/IIIa complex, thereby inhibiting platelet aggregation.
Clopidogrel Bouchara-Recordati is a prodrug of a platelet inhibitor used to reduce the risk of myocardial infarction and stroke. It has a long duration of action as it is taken once daily and a large therapeutic window as it is given in doses of 75-300mg daily.
| Trade Name | Clopidogrel Bouchara-Recordati |
| Availability | Prescription only |
| Generic | Clopidogrel |
| Clopidogrel Other Names | Clopidogrel, Clopidogrelum |
| Related Drugs | aspirin, lisinopril, metoprolol, propranolol, Xarelto, Plavix, Brilinta, enoxaparin, rivaroxaban, pravastatin |
| Type | |
| Formula | C16H16ClNO2S |
| Weight | Average: 321.822 Monoisotopic: 321.059027158 |
| Protein binding | Both the active and inactive metabolites of clopidogrel are 98% protein bound in plasma. Studies in cows show clopidogrel 71-85.5% bound to serum albumin. |
| Groups | Approved |
| Therapeutic Class | Anti-platelet drugs |
| Manufacturer | |
| Available Country | France |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
(Clopidogrel Bouchara-Recordati) is used for the reduction of atherosclerotic events (myocardial infarction, ischaemic stroke, and vascular death) in patients with atherosclerosis documented by recent stroke, recent myocardial infarction, or established peripheral arterial disease.
Clopidogrel Bouchara-Recordati is also used to associated treatment for these conditions: Acute Coronary Syndrome (ACS), Acute Myocardial Infarction (AMI), Cardiovascular Events, Atherothrombotic events
How Clopidogrel Bouchara-Recordati works
Clopidogrel Bouchara-Recordati is metabolized to its active form by carboxylesterase-1. The active form is a platelet inhibitor that irreversibly binds to P2Y12 ADP receptors on platelets. This binding prevents ADP binding to P2Y12 receptors, activation of the glycoprotein GPIIb/IIIa complex, and platelet aggregation.
Dosage
Clopidogrel Bouchara-Recordati dosage
The recommended dose of Lopirel (Clopidogrel Bouchara-Recordati) is 75 mg once daily with or without food.
Side Effects
Generally Clopidogrel Bouchara-Recordati is well tolerated. However, a few common side effects i.e. Influenza-like symptoms, headache, upper respiratory tract infection, dizziness, muscle and back pain, and rash may occur.
Toxicity
A single dose of clopidogrel at 1500-2000mg/kg was lethal to mice and rats while 3000mg/kg was lethal to baboons. Symptoms of overdose include vomiting, breathing difficulty, gastrointestinal hemorrhage, and prostration. Clopidogrel Bouchara-Recordati is irreversibly bound to platelets for their lifetime, which is approximately 11 days. Overdoses of clopidogrel can be treated with platelet transfusions to restore clotting ability.
Precaution
As with other anti-platelet agents, Clopidogrel Bouchara-Recordati should be used with caution in patients who may be at risk of increased bleeding from trauma, surgery, or other pathological conditions. Clopidogrel Bouchara-Recordati should be discontinued 7 days prior to surgery. Clopidogrel Bouchara-Recordati should be used with caution in hepatically impaired patients who may have bleeding diatheses.
Interaction
Concomitant use of Heparin, Warfarin and NSAIDs with Clopidogrel Bouchara-Recordati should be undertaken with caution. Clopidogrel Bouchara-Recordati potentiate the effect of Aspirin on collagen-induced platelet aggregation. The safety of chronic concomitant administration of Aspirin and Clopidogrel Bouchara-Recordati has not been established.
Food Interaction
- Take with or without food.
Clopidogrel Bouchara-Recordati Drug Interaction
Moderate: aspirin, aspirin, aspirin, aspirin, omega-3 polyunsaturated fatty acids, omega-3 polyunsaturated fatty acidsUnknown: ubiquinone, ubiquinone, rosuvastatin, rosuvastatin, metoprolol, metoprolol, metoprolol, metoprolol, cyanocobalamin, cyanocobalamin, ascorbic acid, ascorbic acid, cholecalciferol, cholecalciferol
Clopidogrel Bouchara-Recordati Disease Interaction
Major: bleedingModerate: liver diseaseMinor: renal dysfunction
Volume of Distribution
The apparent volume of distribution of clopidogrel is 39,240±33,520L.
Elimination Route
A 75mg oral dose of clopidogrel is 50% absorbed from the intestine. Clopidogrel Bouchara-Recordati can be taken with or without food. A meal decreases the AUC of the active metabolite by 57%. The active metabolite of clopidogrel reaches a maximum concentration after 30-60 minutes. Clopidogrel Bouchara-Recordati reached a Cmax of 2.04±2.0ng/mL in 1.40±1.07h.
The AUC for a 300mg oral dose of clopidogrel was 45.1±16.2ng*h/mL for poor metabolizers, 65.6±19.1ng*h/mL for intermediate metabolizers, and 104.3±57.3ng*h/mL for extensive metabolizers. The Cmax was 31.3±13ng/mL for poor metabolizers, 43.9±14ng/mL for intermediate metabolizers, and 60.8±34.3ng/mL for extensive metabolizers.
Half Life
That half life of clopidogrel is approximately 6 hours following a 75mg oral dose while the half life of the active metabolite is approximately 30 minutes.
Clearance
The clearance of a 75mg oral dose was 18,960±15,890L/h and for a 300mg oral dose was 16,980±10,410L/h.
Elimination Route
An oral dose of radiolabelled clopidogrel is excreted 50% in the urine and 46% in the feces over 5 days. The remainder of clopidogrel is irreversibly bound to platelets for their lifetime, or approximately 8-11 days.
Pregnancy & Breastfeeding use
Pregnancy: There are no adequate and well-controlled studies of Clopidogrel Bouchara-Recordati in pregnant women. However, Clopidogrel Bouchara-Recordati should be used during pregnancy only if clearly needed.
Lactation: Clopidogrel Bouchara-Recordati is not recommended for use while breast-feeding. It is not known for sure whether Clopidogrel Bouchara-Recordati is excreted in breast milk, although it is suspected that it is.
Contraindication
Clopidogrel Bouchara-Recordati is contraindicated in patients with a hypersensitivity to the drug substance or any component of the product, and those with active pathological bleeding such as peptic ulcer or intracranial hemorrhage.
Special Warning
Use in children: Safety and effectiveness of Clopidogrel Bouchara-Recordati in pediatric population have not been established.
Acute Overdose
In the event of over dosage no adverse effects were reported and no therapy was substituted.
Symptoms: Prolonged bleeding time and subsequent bleeding complications.
Management: May restore clotting ability with platelet transfusion.
Storage Condition
Store at 25° C.
Innovators Monograph
You find simplified version here Clopidogrel Bouchara-Recordati
Clopidogrel Bouchara-Recordati contains Clopidogrel see full prescribing information from innovator Clopidogrel Bouchara-Recordati Monograph, Clopidogrel Bouchara-Recordati MSDS, Clopidogrel Bouchara-Recordati FDA label
FAQ
What is Clopidogrel Bouchara-Recordati used for?
Clopidogrel Bouchara-Recordati is an antiplatelet medication used to reduce the risk of heart disease and stroke in those at high risk. It is also used together with aspirin in heart attacks and following the placement of a coronary artery stent. It prevents platelets from sticking together and forming a dangerous blood clot. Taking Clopidogrel Bouchara-Recordati helps prevent blood clots if you have an increased risk of having them.
How safe is Clopidogrel Bouchara-Recordati?
Clopidogrel Bouchara-Recordati is generally safe to take for a long time. In fact, it works best if you take it for many months or even years. If you're at risk of getting a stomach ulcer, your doctor may prescribe a medicine to help protect your stomach while you're taking Clopidogrel Bouchara-Recordati.
how does Clopidogrel Bouchara-Recordati work?
Clopidogrel Bouchara-Recordati slows the blood's clotting action by making platelets less sticky. Platelets are blood cells that stick together to block cuts and breaks in blood vessels. But if you're at risk of heart attack or stroke, platelets can stick together inside already narrowed blood vessels to form a clot.
What are the common side effects of Clopidogrel Bouchara-Recordati?
Common side effects of Clopidogrel Bouchara-Recordati are include:
- excessive tiredness.
- headache.
- dizziness.
- nausea.
- vomiting.
- stomach pain.
- diarrhea.
- nosebleed.
Is Clopidogrel Bouchara-Recordati safe during pregnancy?
Clopidogrel Bouchara-Recordati can be used throughout pregnancy. There may be another issue related to delivery, however. The patient in question is planning to have a repeat cesarean, and there is some evidence that Clopidogrel Bouchara-Recordati may cause more hemorrhagic complications of surgery.
Is Clopidogrel Bouchara-Recordati safe during breastfeeding?
The manufacturer reports that no adverse effects have been observed in breastfed infants with maternal Clopidogrel Bouchara-Recordati use during lactation in a small number of postmarketing cases.
Can I drink alcohol with Clopidogrel Bouchara-Recordati?
You can drink alcohol with Clopidogrel Bouchara-Recordati. But do not drink too much while taking this medicine.
When should be taken of Clopidogrel Bouchara-Recordati?
It is usually taken once a day with or without food. Take Clopidogrel Bouchara-Recordati at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand.
Can I take Clopidogrel Bouchara-Recordati on an empty stomach?
You can be taken with or without food.
How long does Clopidogrel Bouchara-Recordati take to work?
Clopidogrel Bouchara-Recordati works within 2 hours of taking it.
How is Clopidogrel Bouchara-Recordati eliminated from the body?
An oral dose of radiolabelled Clopidogrel Bouchara-Recordati is excreted 50% in the urine and 46% in the feces over 5 days. The remainder of Clopidogrel Bouchara-Recordati is irreversibly bound to platelets for their lifetime, or approximately 8-11 days.
Is it safe to take Clopidogrel Bouchara-Recordati every other day?
Long term dual anti-platelet therapy with aspirin 81 mg daily and Clopidogrel Bouchara-Recordati 75 mg every other day beyond 12 months after PCI with DES may be a safe and efficacious cost-saving strategy to prevent VLST.
What is Clopidogrel Bouchara-Recordati half-life?
Oral dose of 75 mg, Clopidogrel Bouchara-Recordati has a half-life of approximately 6 hours.
Can I take Clopidogrel Bouchara-Recordati for a long time?
Clopidogrel Bouchara-Recordati oral tablet is used for long-term treatment. It comes with serious risks if you don't take it as prescribed. If you stop taking the drug or don't take it at all: You increase your risk of heart attack or stroke. These conditions can be fatal.
Who should not take Clopidogrel Bouchara-Recordati?
You should not use Clopidogrel Bouchara-Recordati if you have any active bleeding such as a stomach ulcer or bleeding in the brain.Clopidogrel Bouchara-Recordati increases your risk of bleeding, which can be severe or life-threatening. Call your doctor or seek emergency medical attention if you have bleeding that will not stop, if you have blood in your urine, black or bloody stools, or if you cough up blood or vomit that looks like coffee grounds.
What happens if I miss a dose?
Take Clopidogrel Bouchara-Recordati as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.
What happens if I overdose?
Seek emergency medical attention.Overdose can cause excessive bleeding.
Can Clopidogrel Bouchara-Recordati cause heart attacks?
Clopidogrel Bouchara-Recordati may be at increased risk of serious problems like heart attacks or strokes.
Does Clopidogrel Bouchara-Recordati affect the kidneys?
In summary, among patients hospitalized with ACS and treated with Clopidogrel Bouchara-Recordati, lower levels of kidney function were associated with a greater risk of death, hospitalization for AMI, and major bleeding.
Does Clopidogrel Bouchara-Recordati affect sleep?
Clopidogrel Bouchara-Recordati are among the most prescribed drugs in cardiology and are not cited as causing insomnia or sleepiness.
Does Clopidogrel Bouchara-Recordati affect the liver?
Liver damage is a rare side effect of Clopidogrel Bouchara-Recordati.
Does Clopidogrel Bouchara-Recordati weaken immune system?
Clopidogrel Bouchara-Recordati may also cause weak immunosuppression that might contribute to risk of fatal infections.
